By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > ARB > Candesartan

Candesartan

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|655 words

Candesartan: ARB Blood Pressure Medication

What is Candesartan?

Candesartan is an oral medication belonging to a class of drugs called angiotensin receptor blockers (ARBs). It is primarily prescribed to treat high blood pressure (hypertension) and heart failure. This medication works by blocking certain receptors in the body that control blood vessel constriction, helping to lower blood pressure and reduce strain on the heart.

Uses

Candesartan is approved for several cardiovascular conditions:

  • Hypertension: The primary use is treating high blood pressure in adults and children over 6 years old, helping to reduce the risk of stroke, heart attack, and kidney problems
  • Heart failure: Used to treat heart failure in adults when the heart cannot pump blood effectively, often in combination with other heart medications
  • Diabetic nephropathy: May be prescribed to protect kidney function in people with diabetes and high blood pressure
  • Cardiovascular risk reduction: Sometimes used to lower the risk of heart attack and stroke in patients with multiple cardiovascular risk factors
  • Post-heart attack treatment: May be used as part of treatment following a heart attack to improve heart function and survival

How it works

Candesartan blocks angiotensin II receptors in blood vessels, preventing a hormone called angiotensin II from binding to these receptors. When angiotensin II is blocked, blood vessels relax and widen, which lowers blood pressure and reduces the workload on the heart. This mechanism also helps improve blood flow and can protect organs like the kidneys from damage caused by high blood pressure.

Side effects

Common side effects:

Submit Your Paper
GMJ_Submit_Banner
  • Dizziness or lightheadedness
  • Fatigue or weakness
  • Upper respiratory tract infections
  • Back pain
  • Headache
  • Nausea
  • Diarrhea
  • Elevated potassium levels

Serious side effects requiring immediate medical attention:

  • Severe drop in blood pressure causing fainting
  • Signs of kidney problems (decreased urination, swelling)
  • Hyperkalemia (dangerous potassium levels causing irregular heartbeat)
  • Allergic reactions including swelling of face, lips, tongue, or throat
  • Chest pain or irregular heartbeat

Warnings and precautions

  • Pregnancy: Candesartan should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm or death to the developing fetus
  • Kidney disease: Patients with severe kidney disease or those on dialysis should use this medication with extreme caution and require frequent monitoring
  • Liver impairment: People with severe liver disease may need dose adjustments or alternative treatments
  • Dehydration: Patients who are dehydrated, have low sodium levels, or are taking diuretics may experience dangerous drops in blood pressure
  • Elderly patients: Older adults may be more sensitive to blood pressure-lowering effects and require careful monitoring

Interactions

  • Potassium supplements and salt substitutes: Can cause dangerous elevation of potassium levels when combined with candesartan
  • ACE inhibitors: Combining with other blood pressure medications may cause excessive blood pressure reduction and kidney problems
  • NSAIDs (ibuprofen, naproxen): May reduce the blood pressure-lowering effect and increase risk of kidney damage
  • Lithium: Candesartan may increase lithium levels in the blood, potentially causing toxicity
  • Diuretics: May enhance blood pressure-lowering effects, requiring dose adjustments
  • Diabetes medications: May increase the blood sugar-lowering effects of diabetes drugs
  • Warfarin: May affect blood clotting times and require monitoring of INR levels
  • Alcohol: Can enhance blood pressure-lowering effects and increase risk of dizziness

Check interactions with the GMJ Interaction Checker

Dosage

For hypertension in adults, the typical starting dose is 16 mg once daily, which may be increased to 32 mg once daily if needed. For heart failure, treatment usually begins with 4 mg once daily and is gradually increased to a target dose of 32 mg once daily as tolerated. Pediatric dosing for children over 6 years is weight-based and ranges from 4-16 mg once daily. Patients with kidney or liver problems may require lower starting doses. Your healthcare provider will determine the appropriate dose based on your specific condition, response to treatment, and other medications you may be taking.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Candesartan." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/candesartan/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Related topics

Optional further reading from the GMJ knowledge base.

CandesartanDrug
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
How a single stem cell in bone marrow generates your entire immune system

All blood and immune cells originate from a single pluripotent hematopoietic stem…

How amino acids shape brain function: neurotransmitters, energy, and cognitive resilience

Amino acids are the precursors to neurotransmitters and metabolic substrates for brain…

How Coffee and Tea Reduce Iron Absorption: A Mechanism Explained

Polyphenols in coffee and tea bind non-heme iron in the gut, reducing…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Candesartan

By
Prof. Giorgi Pkhakadze
02/06/2026

Olmesartan

By
Prof. Giorgi Pkhakadze
02/06/2026

Telmisartan

By
Prof. Giorgi Pkhakadze
02/06/2026

Irbesartan

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up